ENGOT-ov62 - reducing chemotherapy duration in high-grade advanced ovarian cancer: A comparison of 3 vs. 6 cycles of platinum-based chemotherapy followed by niraparib maintenance in HRD-positive patients

International Journal of Gynecological Cancer 2026 Open access

Read full text
Authors: Jalid Sehouli, Eva Roser, Robert Armbrust, Dario Zocholl, Jessica Nguyen, Jessika Goldmann, Katharina Leitner, Philipp Meyer-Wilmes, Michal Zikán, Beyhan Ataseven, Toon Van Gorp, Suzana Mittelstadt
+4 more Purificación Estévez-García, Michael Eichbaum, Dionyssios Katsaros, Elena Ioana Braicu
DOI: 10.1016/j.ijgc.2025.103769
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy BRCA gene mutations in cancer

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103769–103769
Publication date
1 February 2026
Language
EN